NCT03340506 2026-02-03Dabrafenib and/or Trametinib Rollover StudyNovartisPhase 4 Recruiting100 enrolled
NCT02974725 2025-04-13A Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaNovartisPhase 1 Terminated241 enrolled